“…To the best of our knowledge, the introduction of a functionalized side-chain at the C3-pyrazole carbon of the tetrahydroindazolylbenzamide scaffold is unprecedented, as only alkyl or aryl substituents (e.g., Me, Et, i -Pr, CF 3 , cyclohexyl, Ph, thienyl, etc.) have been introduced so far. ,, In principle, using different amino acids as starting materials for the oxazolone formation, the proposed synthetic methodology might give efficient entry into facile diversification of the side-chain, allowing to maximize the molecular diversity of the final tetrahydroindazolylbenzamide. Moreover, the amino group could be further derivatized to improve the pharmaceutical properties including pharmacokinetic and druggability, i.e., by conjugation with biopolymers.…”